Cryoocyte
Allston, US · Founded 2012 · Delaware corporation · 1 known investors
Founders & leadership
MV
Mike VelingsNamed on SEC filing
JW
James WebbNamed on SEC filing
DK
Dmitry KozachenokNamed on SEC filing
VC
Vladimir CernavskisNamed on SEC filing
TS
Thad SimonsNamed on SEC filing
Board
DB

Investors · 1
Reported raises · per SEC filings
Form D private placements$16.3M disclosed across 5 rounds · 2016–2024
▶$100KraisedApr 2024 · 3 investors · Other TechnologyRule 506(b)
▶$100KraisedApr 2024 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David MatiasDirector
- Vladimir CernavskisDirector
- Dmitry KozachenokExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $100K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$560KraisedJan 2024 · 14 investors · Other TechnologyRule 506(b)
▶$560KraisedJan 2024 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dmitry KozachenokExecutive Officer, Director
- David MatiasDirector
- Offering amount
- $850K
- Amount sold
- $560K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedJul 2021 · 6 investors · Other TechnologyRule 506(b)
▶$7.2MraisedJul 2021 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Vladimir CernavskisDirector
- Thad SimonsDirector
- Kieran FurlongDirector
- Dmitry KozachenokExecutive Officer, Director
- Kim WagenaarDirector
- Offering amount
- $7.6M
- Amount sold
- $7.2M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMay 2021 · 4 investors · Other TechnologyRule 506(b)
▶$3MraisedMay 2021 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Vladimir CernavskisDirector
- Thad SimonsDirector
- Dmitry KozachenokExecutive Officer, Director
- Kim WagenaarDirector
- David B. MatiasDirector
- Offering amount
- $3.4M
- Amount sold
- $3M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedOct 2017 · 16 investors · Other TechnologyRule 506(b)
▶$5.5MraisedOct 2017 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mike VelingsDirector
- James WebbExecutive Officer, Director
- Dmitry KozachenokExecutive Officer, Director
- Vladimir CernavskisExecutive Officer, Director
- Thad SimonsDirector
- David B. MatiasDirector
- Offering amount
- $7.4M
- Amount sold
- $5.5M
- Proceeds to insiders
- $150K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cryoocyte's investors?
- Cryoocyte's investors include Vodia Ventures.
- How much funding has Cryoocyte raised?
- Cryoocyte has disclosed $16.3M raised across 5 rounds.
- Where is Cryoocyte headquartered?
- Cryoocyte is headquartered in Allston, US.